Biopharmaceutical import value in South Korea 2019, by product type

Published by Statista Research Department, Dec 14, 2022
In 2019, genetically modified drugs were the most imported biopharmaceutical product in South Korea, with an import value of around 1.06 trillion U.S. dollars. This put it far ahead of all other product types, with vaccines coming in second at around 230.8 million dollars in import value.

Value of biopharmaceuticals imported into South Korea in 2019, by type of product (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

October 2021

Region

South Korea

Survey time period

2019

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

5

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in South KoreaHealthcare in South Korea Demographics of South KoreaCoronavirus (COVID-19) in South KoreaMedical tourism in South Korea
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu